Mupirocin
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: MRC, Pseudomonic acid, Mupirocine, mupirocin, Bactoderm, Bactroban, Bactroban Nasal, Centany, Turixin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Dosing and Administration
A small amount of Bactroban Ointment should be applied to the affected area three times daily.
The area treated may be covered with a gauze dressing if desired. Patients not showing a clinical
response within 3 to 5 days should be re-evaluated.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
FDA label
FDA on Mupirocin
Return to top
Publication Resources
Most Recent Articles on Mupirocin
Review Articles on Mupirocin
Articles on Mupirocin in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Mupirocin
Return to top
Trial Resources
Ongoing Trials with Mupirocin at Clinical Trials.gov
Trial Results with Mupirocin
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Mupirocin
Cochrane Collaboration on Mupirocin
Cost Effectiveness of Mupirocin
Return to top
Media Resources
Powerpoint Slides on Mupirocin
Images of Mupirocin
Podcasts & MP3s on Mupirocin
Videos on Mupirocin
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Mupirocin
Discussion Groups on Mupirocin
Patient Handouts on Mupirocin
Blogs on Mupirocin
Mupirocin in the News
Mupirocin in the Marketplace
Return to top
International Resources
Mupirocin en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Decongestants and other nasal preparations (R01) | |
|---|---|
| Topical: sympathomimetics, plain | Cyclopentamine - Ephedrine - Phenylephrine - Oxymetazoline - Tetryzoline - Xylometazoline - Naphazoline - Tramazoline - Metizoline - Tuaminoheptane - Fenoxazoline - Tymazoline - Epinephrine |
| Topical: antiallergic agents, excluding corticosteroids | Cromoglicic acid - Levocabastine - Azelastine - Antazoline - Spaglumic acid - Thonzylamine - Nedocromil - Olopatadine |
| Topical: corticosteroids | Beclometasone - Prednisolone - Dexamethasone - Flunisolide - Budesonide - Betamethasone - Tixocortol - Fluticasone - Mometasone furoate - Triamcinolone - Ciclesonide |
| Topical: other nasal preparations | Calcium hexamine thiocyanate - Retinol - Ipratropium bromide - Ritiometan - Mupirocin - Hexamidine - Framycetin |
| Systemic use: Sympathomimetics | Phenylpropanolamine - Pseudoephedrine - Phenylephrine |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
